Smith, D. C., Tangen, C. M., Hussain, M. H., Van Veldhuizen, P. J., Harrer, G. W., Stuart, R. K., . . . Thompson, I. M. (2011). Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination with Hormone Therapy in Patients with High-Risk Metastatic Adenocarcinoma of the Prostate: Southwest Oncology Group (SWOG) S0032.

Smith, David C., Cathy M. Tangen, Maha H.A Hussain, Peter J. Van Veldhuizen, Grant W. Harrer, Robert K. Stuart, Glenn M. Mills, Nicholas J. Vogelzang, and Ian M. Thompson. Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination With Hormone Therapy in Patients With High-Risk Metastatic Adenocarcinoma of the Prostate: Southwest Oncology Group (SWOG) S0032. 2011.

Smith, David C., et al. Phase II Evaluation of Early Oral Estramustine, Oral Etoposide and Intravenous Paclitaxel in Combination With Hormone Therapy in Patients With High-Risk Metastatic Adenocarcinoma of the Prostate: Southwest Oncology Group (SWOG) S0032. 2011.